The clinical use of biomarkers as prognostic factors in Ewing sarcoma

Table 4 Outcome for phenotypic marker: histological response

Author	Year	Pt number	P
Delepine et al, J Chemother 9 (5), 352-63[49]	1997	39	0.05
Picci et al, J Clin Oncol 15 (4), 1553-9[50]	1997	118	0.0001
Aparicio et al, Oncology 55, 20-6[9]	1998	116	0.018
Paulussen et al, J Clin Oncol 16 (9), 3044-52[39]	1998	114	S
Abudu et al, J Bone Joint Surg 81 (2), 317-22[51]	1999	50	0.03
Ahrens et al, Med Pediatr Oncol 32, 186-95[10]	1999	177	0.27
Baldini et al, Ann Surg 230 (1), 79-86[40]	1999	37	0.01
Bacci et al, J Clin Oncol 18, 4-11[13]	2000	359	0.001
De Alava et al, Cancer 89, 783-92[25]	2000	55	0.001
Ohali et al, J Clin Oncol 21, 3836-43[52]	2003	31	0.0001
Scotlandi et al, Eur J Cancer 41, 1349-61[53]	2005	113	0.05
Bacci et al, Acta Oncol 45, 469-75[16]	2006	579	0.0005
Mikulic et al, J Pediatr Surg 41, 524-9[31]	2006	27	0.047
Avigad et al, Clin Cancer Res 13 (19), 5777-83[54]	2007	32	0.13
Yonemori, J Cancer Res Clin Oncol 134, 389-95v [34]	2008	79	0.04
Meynet et al, Cancer Res 70 (9), 3730-8[55]	2010	97	0.02

ISSN: 2045-3329